2015
DOI: 10.1016/j.jdiacomp.2015.04.012
|View full text |Cite
|
Sign up to set email alerts
|

PPARγ–PI3K/AKT–NO signal pathway is involved in cardiomyocyte hypertrophy induced by high glucose and insulin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
16
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(17 citation statements)
references
References 28 publications
(31 reference statements)
1
16
0
Order By: Relevance
“…However, iNOS is absent in healthy rat heart, while highly expressed under pathological conditions, such as ischemia, hyperglycemia, and inflammation . Increasing evidences suggested that phosphorylation of eNOS, the target of Akt, was an important downstream effector in survival signaling in cardiomyocytes . Raleigh et al demonstrated that recombinant human relaxin‐2 (serelaxin) protects myocardium against I‐R injury by eNOS activation, while eNOS knock out abolished serelaxin's beneficial effects.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, iNOS is absent in healthy rat heart, while highly expressed under pathological conditions, such as ischemia, hyperglycemia, and inflammation . Increasing evidences suggested that phosphorylation of eNOS, the target of Akt, was an important downstream effector in survival signaling in cardiomyocytes . Raleigh et al demonstrated that recombinant human relaxin‐2 (serelaxin) protects myocardium against I‐R injury by eNOS activation, while eNOS knock out abolished serelaxin's beneficial effects.…”
Section: Discussionmentioning
confidence: 99%
“…28 Increasing evidences suggested that phosphorylation of eNOS, the target of Akt, was an important downstream effector in survival signaling in cardiomyocytes. [29][30][31] Raleigh et al 32 to myocardial injury by nitrative stress. 35,36 Thereby, these findings may on account of different disease models, type, and dose of drugs.…”
Section: Discussionmentioning
confidence: 99%
“…Recent evidence shows that cardiac insulin signaling is hyperactive in a pathological hypertrophic model induced by pressure overload [55]. Genetic inhibition of the InsR-Akt1 signaling pathway substantially attenuates hypertrophy, adverse remodeling, and dysfunction following transverse aortic constriction [55, 5962]. Thus, activation of InsR signaling in pressure overload model appears to promote detrimental pathological hypertrophy.…”
Section: Hyperinsulinemia Promotes Cardiac Remodeling: Hypertrophy Anmentioning
confidence: 99%
“…Moreover, it was suggested that exosomal 15d-PGJ2 was already activated by PPAR-γ before entering recipient cells, because PPAR-γ was also enriched in exosomes from human plasma (Looze et al, 2009). Because PPARγ activation was demonstrated to attenuate cardiomyocyte hypertrophy induced by high glucose and insulin (Chen et al, 2015; Peng et al, 2015), exosomal 15d-PGJ2 is a promising strategy for preventing cardiomyopathy in patients with diabetes.…”
Section: Other Types Of Exosomal Cargoesmentioning
confidence: 99%